These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 21402637)

  • 41. Sleep disordered breathing in infants with Prader-Willi syndrome during the first 6 weeks of growth hormone therapy: a pilot study.
    Miller JL; Shuster J; Theriaque D; Driscoll DJ; Wagner M
    J Clin Sleep Med; 2009 Oct; 5(5):448-53. PubMed ID: 19961030
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exacerbation of BMI after cessation of growth hormone therapy in patients with Prader-Willi syndrome.
    Oto Y; Tanaka Y; Abe Y; Obata K; Tsuchiya T; Yoshino A; Murakami N; Nagai T
    Am J Med Genet A; 2014 Mar; 164A(3):671-5. PubMed ID: 24443368
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is growth hormone treatment in children associated with weight gain?--longitudinal analysis of KIGS data.
    Reinehr T; Lindberg A; Koltowska-Häggström M; Ranke M
    Clin Endocrinol (Oxf); 2014 Nov; 81(5):721-6. PubMed ID: 24750131
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits.
    Myers SE; Whitman BY; Carrel AL; Moerchen V; Bekx MT; Allen DB
    Am J Med Genet A; 2007 Mar; 143A(5):443-8. PubMed ID: 17103437
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Growth charts for children aged 6-17 years in Shanxi, China: comparison with other cities of China and WHO.
    Hou G; Li K; Cao W; Tao M; Tian W; Chang R
    BMC Pediatr; 2024 Jul; 24(1):423. PubMed ID: 38956525
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term growth hormone therapy changes the natural history of body composition and motor function in children with prader-willi syndrome.
    Carrel AL; Myers SE; Whitman BY; Eickhoff J; Allen DB
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1131-6. PubMed ID: 20061431
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).
    Craig ME; Cowell CT; Larsson P; Zipf WB; Reiter EO; Albertsson Wikland K; Ranke MB; Price DA;
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):178-85. PubMed ID: 16886957
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The growth hormone response to hexarelin in patients with Prader-Willi syndrome.
    Cappa M; Raguso G; Palmiotto T; Faedda A; Gurreri F; Neri G; Deghenghi R; Loche S
    J Endocrinol Invest; 1998 Sep; 21(8):501-5. PubMed ID: 9801990
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Growth hormone secretion decreases with age in paediatric Prader-Willi syndrome.
    Cohen M; Harrington J; Narang I; Hamilton J
    Clin Endocrinol (Oxf); 2015 Aug; 83(2):212-5. PubMed ID: 25495188
    [TBL] [Abstract][Full Text] [Related]  

  • 50. What is the value of growth hormone therapy in Prader Willi syndrome?
    Bridges N
    Arch Dis Child; 2014 Feb; 99(2):166-70. PubMed ID: 24162007
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of minipuberty in infants with Prader-Willi syndrome.
    Hirsch HJ; Eldar-Geva T; Erlichman M; Pollak Y; Gross-Tsur V
    Horm Res Paediatr; 2014; 82(4):230-7. PubMed ID: 25170853
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disease-specific Growth Charts of Marfan Syndrome Patients in Korea.
    Kwun Y; Kim SJ; Lee J; Isojima T; Choi DS; Kim DK; Huh J; Kang IS; Chang M; Cho SY; Sohn YB; Park SW; Jin DK
    J Korean Med Sci; 2015 Jul; 30(7):911-6. PubMed ID: 26130954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of growth hormone therapy on glucose metabolism and insulin sensitivity indices in prepubertal children with Prader-Willi syndrome.
    Crinò A; Di Giorgio G; Manco M; Grugni G; Maggioni A
    Horm Res; 2007; 68(2):83-90. PubMed ID: 17337902
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development and implementation of electronic growth charts for infants with Prader-Willi syndrome.
    Rosenbloom ST; Butler MG
    Am J Med Genet A; 2012 Nov; 158A(11):2743-9. PubMed ID: 22903930
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The weight and height percentiles in 6-18 year old children in Kayseri and comparison with Istanbul data.
    Hatipoğlu N; Kurtoğlu S; Oztürk A; Mazıcıoğlu MM
    J Clin Res Pediatr Endocrinol; 2009; 1(3):129-35. PubMed ID: 21274397
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The 2022 Pakistani references from birth to 60 months for length/height, weight and body mass index.
    Akbar N; Aslam M; Petersen JH; Mustafa G
    Acta Paediatr; 2023 Jun; 112(6):1249-1258. PubMed ID: 36945788
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Developmental profiles in young children with Prader-Labhart-Willi syndrome: effects of weight and therapy with growth hormone or coenzyme Q10.
    Eiholzer U; Meinhardt U; Rousson V; Petrovic N; Schlumpf M; l'Allemand D
    Am J Med Genet A; 2008 Apr; 146A(7):873-80. PubMed ID: 18257095
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bone mineral density in children and adolescents with Prader-Willi syndrome: a longitudinal study during puberty and 9 years of growth hormone treatment.
    Bakker NE; Kuppens RJ; Siemensma EP; Tummers-de Lind van Wijngaarden RF; Festen DA; Bindels-de Heus GC; Bocca G; Haring DA; Hoorweg-Nijman JJ; Houdijk EC; Jira PE; Lunshof L; Odink RJ; Oostdijk W; Rotteveel J; Van Alfen AA; Van Leeuwen M; Van Wieringen H; Wegdam-den Boer ME; Zwaveling-Soonawala N; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1609-18. PubMed ID: 25668198
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Visceral adipose tissue resides within the reference range in children with Prader-Willi syndrome receiving nutritional intervention on a regular basis.
    Koizumi M; Ida S; Shoji Y; Nishimoto Y; Etani Y; Kawai M
    Endocr J; 2020 Oct; 67(10):1029-1037. PubMed ID: 32565499
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The efficacy and safety of long-term Norditropin® treatment in children with Prader-Willi syndrome.
    Meinhardt U; Christiansen JS; Farholt S; Lämmer C; Ostergaard JR; Schmidt F; Kappelgaard AM; Eiholzer U
    Horm Metab Res; 2013 Jul; 45(7):532-6. PubMed ID: 23632904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.